Advisory Council for the Elimination of Tuberculosis Meeting (ACET), 54600 [E8-22040]
Download as PDF
<![CDATA[
54600
Federal Register / Vol. 73, No. 184 / Monday, September 22, 2008 / Notices
Dated: September 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. E8–22040 Filed 9–19–08; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
sroberts on PROD1PC70 with NOTICES
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
BILLING CODE 4163–18–P
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following council
meeting.
Times and Dates:
8:30 a.m.–5:30 p.m., October 7, 2008.
8:30 a.m.–2 p.m., October 8, 2008.
Place: Corporate Square, Building 8,
1st Floor Conference Room, Atlanta,
Georgia 30333, Telephone (404) 639–
8317.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 100
people.
Purpose: This council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis.
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters to be Discussed: Agenda items
include issues pertaining to update on
nucleic acid amplification guidelines;
update on interferon gamma release
assays guidelines; update on the
isolation guidelines; update on travel
restrictions guidelines and other related
tuberculosis issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, Coordinating Center
for Infectious Diseases, Strategic
Business Unit, 1600 Clifton Road, NE.,
M/S E–07, Atlanta, Georgia 30333,
Telephone (404) 639–8317.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Aug<31>2005
19:11 Sep 19, 2008
Jkt 214001
Food and Drug Administration
[Docket No. FDA–2008–D–0372]
Global Harmonization Task Force,
Study Groups 1 and 5; Proposed and
Final Documents; Availability;
Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
The Food and Drug
Administration (FDA) is correcting a
notice that appeared in the Federal
Register of July 11, 2008 (73 FR 39968).
The notice announced the availability of
Global Harmonization Task Force
documents entitled ‘‘Role of Standards’’
and ‘‘Clinical Investigations.’’ The
notice was published with an incorrect
document number. This document
corrects that number.
FOR FURTHER INFORMATION CONTACT: Paul
Gadiock, Center for Devices and
Radiological Health (HFZ–215), Food
and Drug Administration, 1350 Piccard
Dr., Rockville, MD 20850, 240–276–
2343.
SUMMARY:
In FR Doc.
E8–15797, appearing on page 39968 in
the Federal Register of Friday, July 11,
2008, the following correction is made:
1. On page 39968, in the third
column, in the third paragraph, in the
8th and 9th lines, ‘‘SG5(PD)/N37:2007’’
is corrected to read ‘‘SG5(PD)/
N3R7:2007.’’
SUPPLEMENTARY INFORMATION:
Dated: September 11, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–22094 Filed 9–19–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Biophysics of Neural
Systems Study Section, October 2, 2008,
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
8 am to October 3, 2008, 5 pm, One
Washington Circle Hotel, One
Washington Circle, Washington, DC
20037 which was published in the
Federal Register on September 9, 2008,
73 FR 52395–52397.
The meeting will be held one day
only October 2, 2008, from 8 am to 8
pm. The meeting location remains the
same. The meeting is closed to the
public.
Dated: September 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–22055 Filed 9–19–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive And Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; R13 Conference
Application.
Date: October 23, 2008.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: D.G. Patel, PhD, Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
756, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7682,
pateldg@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Ancillary Study for
PKD.
Date: October 27, 2008.
Time: 12 p.m. to 2 p.m.
E:\FR\FM\22SEN1.SGM
22SEN1
]]>Agencies
[Federal Register Volume 73, Number 184 (Monday, September 22, 2008)]
[Notices]
[Page 54600]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-22040]
[[Page 54600]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis Meeting
(ACET)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following council meeting.
Times and Dates:
8:30 a.m.-5:30 p.m., October 7, 2008.
8:30 a.m.-2 p.m., October 8, 2008.
Place: Corporate Square, Building 8, 1st Floor Conference Room,
Atlanta, Georgia 30333, Telephone (404) 639-8317.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 100 people.
Purpose: This council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis. Specifically, the Council makes recommendations regarding
policies, strategies, objectives, and priorities; addresses the
development and application of new technologies; and reviews the extent
to which progress has been made toward eliminating tuberculosis.
Matters to be Discussed: Agenda items include issues pertaining to
update on nucleic acid amplification guidelines; update on interferon
gamma release assays guidelines; update on the isolation guidelines;
update on travel restrictions guidelines and other related tuberculosis
issues.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh,
Coordinating Center for Infectious Diseases, Strategic Business Unit,
1600 Clifton Road, NE., M/S E-07, Atlanta, Georgia 30333, Telephone
(404) 639-8317.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: September 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. E8-22040 Filed 9-19-08; 8:45 am]
BILLING CODE 4163-18-P
